Mid Atlantic Bio Angels Invests $500K in Cerus Endovascular
Mid Atlantic Bio Angels, an angel investor group focused on new and emerging life science companies, said on Wednesday that it has invested $500,000 in Cerus Endovascular Ltd., a company in Oxford, England, which has developed an implantable device for treating aneurysms. According to Cerus Endovascular, the funding, which was part of a larger investment round, will be used for product development and clinical trials.
5 June 2013•2 mins read
